|
[Related PubMed/MEDLINE] Total Number of Papers: 60
|
|
|
[Entries Per Page]
|
per page
|
|
Page Control
|
|
Page: of |
|
|
|
No. |
Year |
Title |
Co-occurring Abbreviation |
1 |
2020 |
Clinicopathological concordance in cognitive disease diagnostics. |
AD, FTD, LBD, VaD |
2 |
2020 |
Diagnostic accuracy of the Montreal Cognitive Assessment (MoCA) for cognitive screening in old age psychiatry: Determining cutoff scores in clinical practice. Avoiding spectrum bias caused by healthy controls. |
AUC, MCI, MoCA, NPV, PPV |
3 |
2020 |
The CITIMEM study: A pilot study. Optimizing pharmacological treatment in dementia. |
AD, NMDA |
4 |
2020 |
Validation of the Argentine version of the Montreal Cognitive Assessment Test (MOCA): A screening tool for Mild Cognitive Impairment and Mild Dementia in Elderly. |
MCI, MoCA |
5 |
2019 |
Autophagy and mitophagy biomarkers are reduced in sera of patients with Alzheimer's disease and mild cognitive impairment. |
AD, MCI, VaD |
6 |
2019 |
Introducing a Novel Approach for Evaluation and Monitoring of Brain Health Across Life Span Using Direct Non-invasive Brain Network Electrophysiology. |
DELPHI, EEG, TMS |
7 |
2018 |
Clock Drawing Test: A Simple Scoring System for the Accurate Screening of Cognitive Impairment in Patients with Mild Cognitive Impairment and Dementia. |
AD, CDT, MCI, MMSE |
8 |
2018 |
High Occurrence of Psychiatric Disorders and Suicidal Behavior Across Dementia Subtypes. |
AD, FTD, LBD, SPAN, VA, VD |
9 |
2018 |
Use of Speech Analyses within a Mobile Application for the Assessment of Cognitive Impairment in Elderly People. |
AD, MCI, SCI |
10 |
2017 |
Association of adiponectin, leptin and resistin with inflammatory markers and obesity in dementia. |
AD, IL-6, VaD |
11 |
2017 |
Clinical Spectrum, Risk Factors, and Behavioral Abnormalities among Dementia Subtypes in a North Indian Population: A Hospital-Based Study. |
AD, FTD, PWD, VaD |
12 |
2017 |
Plasma levels of soluble receptor for advanced glycation end products in Alzheimer's disease. |
AD, OD, sRAGE, VaD |
13 |
2016 |
Comparison of neuropsychological profiles in patients with Alzheimer's disease and mixed dementia. |
AD, CDR, CREDOS |
14 |
2016 |
Decreased arylesterase activity of paraoxonase-1 (PON-1) might be a common denominator of neuroinflammatory and neurodegenerative diseases. |
CSF, HDL, LOAD, MCI, MS, PON1, VaD |
15 |
2016 |
Evolution of the Antidepressant Prescribing in Alzheimer's Disease and Related Disorders Between 2010 and 2014: Results from the French National Database on Alzheimer's Disease (BNA). |
AD, VaD |
16 |
2016 |
The CITIRIVAD Study: CITIcoline plus RIVAstigmine in Elderly Patients Affected with Dementia Study. |
AchEIs, AD, ADL, GDS, MMSE, NPI |
17 |
2016 |
[Clinical and neuropsychological features of Alzheimer's disease in the combination with cerebrovascular disease]. |
ACE-R, CVD, MoCA |
18 |
2016 |
[Cognitive rehabilitation in early stage Alzheimer's disease]. |
CR, MCI |
19 |
2015 |
Validation of the Montreal Cognitive Assessment (MoCA) in Spanish as a screening tool for mild cognitive impairment and mild dementia in patients over 65 years old in Bogota, Colombia. |
MCI, MoCA, MoCA-S |
20 |
2014 |
Functional disorganization of small-world brain networks in mild Alzheimer's Disease and amnestic Mild Cognitive Impairment: an EEG study using Relative Wavelet Entropy (RWE). |
AD, aMCI, EEG, ODWT, RWE, SW |
21 |
2014 |
[Clinical, neuropsychological and neuroimaging features of patients with mixed dementia]. |
AD |
22 |
2013 |
Clinical and autonomic profile of patients with Alzheimer's disease and mixed dementia patients. |
HR, LF |
23 |
2013 |
Neuropsychiatric Symptoms (NPS) in patients with pure Vascular Dementia (VaD) and Mixed Dementia (MD) from a memory outpatient clinic in southeast Brazil. |
NPS, VaD, VCI |
24 |
2013 |
Paraoxonase 1 (PON1) gene-108C>T and p.Q192R polymorphisms and arylesterase activity of the enzyme in patients with dementia. |
AD, PON1 |
25 |
2013 |
Patterns of neuropsychological impairment in Alzheimer's disease and mixed dementia. |
AD, CVD |
26 |
2013 |
[The importance of folic acid deficiency in the pathogenesis of vascular, mixed and Alzheimer's disease dementia]. |
AD, CDR, FOL, MMSE, VaD |
27 |
2012 |
DAD-6: A 6-ltem version of the Disability Assessment for Dementia scale which may differentiate Alzheimer's disease and mild cognitive impairment from controls. |
DAD, MCI |
28 |
2012 |
Early biomarkers for post-stroke cognitive impairment. |
NEP, sRAGE, VaD, VCIND |
29 |
2012 |
Validation of the neurobehavioral cognitive status examination and the Rivermead Behavioural Memory Test in investigations of dementia. |
MCI, MMSE |
30 |
2011 |
Cerebrospinal fluid matrix metalloproteinases and tissue inhibitor of metalloproteinases in combination with subcortical and cortical biomarkers in vascular dementia and Alzheimer's disease. |
AD, CSF, H-FABP, MBP, NFL, SVD, t-tau, VaD |
31 |
2011 |
Mild cognitive impairment, degenerative and vascular dementia as predictors of intra-hospital, short- and long-term mortality in the oldest old. |
AD, MCI, VaD |
32 |
2010 |
Cognitive profiles of incipient dementia in the Goteborg MCI study. |
AD, MCI, VaD |
33 |
2010 |
Management of mixed dementia. |
AD, VaD |
34 |
2010 |
Telomere length and ApoE polymorphism in mild cognitive impairment, degenerative and vascular dementia. |
AD, MCI |
35 |
2009 |
A possible role of atrial fibrillation as a risk factor for dementia. |
AD, ADL, AF, CDR, IADL, MMSE, VaD |
36 |
2009 |
CSF biomarker profile and diagnostic value in vascular dementia. |
AD, CSF, ELISA, VD |
37 |
2009 |
The role of the -427T/C apolipoprotein E promoter polymorphism in the pathogenesis of Alzheimer's disease, vascular dementia and mixed dementia. |
AD |
38 |
2008 |
Demented versus non-demented very old inpatients: the same comorbidities but poorer functional and nutritional status. |
AD, ADL, BMI, CCI, FIM, IADL, MCI, MNA, VaD |
39 |
2008 |
Utility of different MR modalities in mild cognitive impairment and its use as a predictor of conversion to probable dementia. |
AD, ADC, Cho, Cr, DeMCI, DWI, LBD, LOC, MCI, mI, MRS, NAA, PCG, PI, VaMCI |
40 |
2008 |
[Evaluation of the capacity to drive in patients diagnosed of mild cognitive impairment and dementia]. |
MCI, RBANS, TMT, UFOV |
41 |
2007 |
Brain type carnosinase in dementia: a pilot study. |
AD |
42 |
2007 |
Effectiveness of a cognitive rehabilitation program in mild dementia (MD) and mild cognitive impairment (MCI): a case control study. |
AD, MCI |
43 |
2007 |
Neuropathological evaluation of mixed dementia. |
AD, CVD, VaD |
44 |
2007 |
Telephonic Remote Evaluation of Neuropsychological Deficits (TREND): longitudinal monitoring of elderly community-dwelling volunteers using touch-tone telephones. |
ADAS, CN, IVR, MCI, TREND |
45 |
2007 |
Validation of clinical criteria for possible vascular dementia in the oldest-old. |
ADDTC, HIS, VaD |
46 |
2006 |
Differences in risk factors for dementia with neurodegenerative traits and for vascular dementia. |
AD, APOE, IL, LDL |
47 |
2006 |
Differential deposition of amyloid beta peptides in cerebral amyloid angiopathy associated with Alzheimer's disease and vascular dementia. |
AD, CAA, VaD |
48 |
2006 |
Polymorphism of apolipoproteine E in relation with Alzheimer and vascular dementia. |
AD, CI, MMSE, OR, VD |
49 |
2005 |
Risperidone for psychosis of Alzheimer's disease and mixed dementia: results of a double-blind, placebo-controlled trial. |
AD, BEHAVE-AD, CGIC |
50 |
2005 |
[Mixed dementia: a neuropathologic point od view]. |
AD, VaD |
51 |
2003 |
Important link between dementia subtype and apolipoprotein E: a meta-analysis. |
AD, APOE, LBD, NAVD, OR, VD |
52 |
2002 |
Apolipoprotein E epsilon 4 allele frequency in demented and cognitively impaired patients with and without cerebrovascular disease. |
AD, APOE, CVD, MCI, NC, VaD |
53 |
2002 |
Mixed dementia: epidemiology, diagnosis, and treatment. |
AD, VaD |
54 |
2002 |
Neuropsychological differentiation of small vessel disease, Alzheimer's disease and mixed dementia. |
--- |
55 |
1999 |
Apolipoprotein E phenotypes in demented and cognitively impaired patients with and without cerebrovascular disease. |
AD, APOE, CVD, MCI, VaD, VMCI |
56 |
1996 |
Full-information models for multiple psychometric tests: annualized rates of change in normal aging and dementia. |
AD, BNT, DRS, MMSE, VD, WRB |
57 |
1996 |
Vision in dementia: contrast effects. |
AD, VD |
58 |
1995 |
Survival and dementia: a 7-year follow-up of an Italian elderly population. |
AD, MID |
59 |
1991 |
Dementia: case ascertainment in a community survey. |
AD, MID |
60 |
1990 |
[Neuropathologic study of 50 cases of senile dementia]. |
SDAT, VD |
|